Floatz logo

ETOPOSIDE

Hypodiploidy

Fred Hutchinson Cancer CenterSmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Hypodiploidy cohort.

Asset / SponsorPhaseRating
Fludarabine
Fred Hutchinson Cancer Center
Phase 2B
CARMUSTINE
Fred Hutchinson Cancer Center
Phase 2B
Cytosin-Arabinosid
Fred Hutchinson Cancer Center
Phase 2B
Cyclophosphamide
Fred Hutchinson Cancer Center
Phase 2B
TACROLIMUS
Fred Hutchinson Cancer Center
Phase 2B
Evomela
Fred Hutchinson Cancer Center
Phase 2B

Same molecule, other indications

ETOPOSIDE is also rated in:

acute megakaryoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
acute monocytic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
acute myeloblastic leukemia with maturationDormant
BBB
Indicative ·
79 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →